Vaxcyte, Inc. — Director's Dealing 2025

Mar 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-12-31

Reporting Person: Wassil Jim (CHIEF OPERATING OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-31	Common Stock	G	74000	—	Disposed	131695	Direct

Footnotes

F1: Represents a transfer of ownership of the Issuer's common stock to a charitable remainder trust of which the Reporting Person is not a trustee. This transaction is being reported late due to a delay in receiving the transaction information from the Reporting Person's broker and is being reported promptly upon discovery.